Your browser doesn't support javascript.
loading
Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy.
Cao, Wenyue; Wei, Jia; Wang, Na; Xu, Hao; Xiao, Min; Huang, Lifang; Cao, Yang; Li, Chunrui; Xiao, Yi; Gu, Chaojiang; Zhang, Shangkun; Li, Dengju; Zhang, Yichen; Zhang, Tongcun; Zhou, Jianfeng; Huang, Liang.
Afiliação
  • Cao W; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China.
  • Wei J; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, China.
  • Wang N; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China.
  • Xu H; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, China.
  • Xiao M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China.
  • Huang L; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, China.
  • Cao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China.
  • Li C; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, China.
  • Xiao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China.
  • Gu C; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, China.
  • Zhang S; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China.
  • Li D; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, China.
  • Zhang Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China.
  • Zhang T; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, China.
  • Zhou J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China.
  • Huang L; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, China.
Blood ; 136(4): 516-519, 2020 07 23.
Article em En | MEDLINE | ID: mdl-32291456
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Viral / Vírus da Hepatite B / Imunoterapia Adotiva / Guanina / Hepatite B Tipo de estudo: Etiology_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Viral / Vírus da Hepatite B / Imunoterapia Adotiva / Guanina / Hepatite B Tipo de estudo: Etiology_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article